Latest Breaking News On - Phagenova bio - Page 1 : comparemela.com

Published: Dec 10, 2020   NEW YORK, Dec. 10, 2020 /PRNewswire/  PhageNova Bio, Inc. ( PhageNova ) is pleased to announce the publication of data generated through a sponsored research agreement with Rutgers, The State University of New Jersey. The Med (a Cell Press publication) article, entitled Targeted Phage Display-Based Pulmonary Vaccination in Mice and Non-human Primates, describes a new method for safe and effective pulmonary delivery of therapeutics, including an aerosol vaccination strategy which is being developed to address the current SARS-CoV-2 pandemic. Our targeted method of pulmonary delivery is the initial step towards the development of aerosol phage-based vaccines for human applications against multiple diseases, says Renata Pasqualini, PhD, co-senior study author, Founder and Chief Scientific Officer of PhageNova, and Chief of the Division of Cancer Biology, Department of Radiation Oncology at Rutgers Cancer Institute and Rutgers New Jersey Medic

New jerseyUnited statesJason rifkinRenata pasqualiniPhagenova bioUniversity of new jerseyDivision of cancer biologyRutgers new jersey medical schoolRutgers cancer instituteAa cellPhagenova bio incState universityCell pressNon human primatesChief scientific officerCancer biology